March 15, 2026 · Form 4 insider transaction
MAHON PAUL A bought 8,895 shares of United Therapeutics Corporation, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock.